At this year’s International AIDS Conference (AIDS 2018) in Amsterdam, the Netherlands, we witnessed several pivotal developments in the global HIV response. We also saw some setbacks in our efforts to prevent infections and improve the lives of people living with HIV. From clinical science and epidemiology to human rights and advocacy, here are some highlights of the good news and the bad news from AIDS 2018.
The Canadian Network on Hepatitis C (CanHepC) is leading a national effort to develop a consensus blueprint to meet the World Health Organization’s hepatitis C elimination targets by 2030. The goal of the blueprint is to guide various stakeholders with specific and measurable objectives on how to address hepatitis C in different Canadian contexts. I’m excited for the initial draft of the blueprint, coming out this fall, as it will greatly impact my work.
Canada is one of 194 countries that endorsed the World Health Organization’s Global Health Sector Strategy on Viral Hepatitis in 2016, committing to – among other things – the elimination of viral hepatitis as a major public health threat by 2030. But what does eliminating viral hepatitis mean in practice? The recent Global Hepatitis Summit in Toronto from June 14 to 17, 2018, brought together researchers, healthcare providers, and public health practitioners from around the world to try to answer this question. Presenters shared the latest research findings, marked which countries are on track to meet the targets, and discussed...
Depuis plus de 10 ans que nous attendions ce moment : les sites d’injection supervisée (SIS) sont arrivés! Nous y voilà rendus! Ça fait bientôt un an que nous sommes ouverts. Mise en contexte : les SIS sont un projet régional qui est chapeauté par plusieurs structures. Quatre organismes communautaires, dont Dopamine, et le Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l’Île-de-Montréal sont dans le coup et assurent les ressources humaines nécessaires pour mettre en place un tel service. Ceci dit, Dopamine est un organisme en réduction des méfaits qui travaille en prévention VIH, VHC et autres ITSS dans...
I don’t really like medical spaces. For me, they’re not just spaces that are essential to my health, but also spaces of exclusion and trauma. How often have I heard about people from my communities being refused care? A chronic migraine blamed on hormones. An open wound left unbandaged because they “don’t have the expertise necessary to deal with that kind of people”. And what about inappropriate questions, wrong names on files, or deadnames read out loud in the waiting room, in front of everyone?
Historically, people living with HIV in Canada have been excluded from access to life insurance. In recent years, however, both Manulife and Sun Life have started accepting applications from people living with HIV, now that HIV is widely recognized as a manageable chronic illness. Nevertheless, this significant change in policy is not well-known within the HIV sector. How can we change that and how can we facilitate access to life insurance for people living with HIV? With these two questions in mind, we at Realize and the Canadian Positive People Network (CPPN) surveyed our members and the insurance sector to...
